Detailed information about the course
Title | Visit to Debiopharm |
Dates | 29 September 2022 |
Organizer(s) | Emilie Trachsel PhD student Dept. Microbiology & Molecular Medicine University of Geneva |
Speakers | |
Description | Objectives: Give the opportunity for PhD students to meet potential future employers, and understand practical aspects of the job directly on site. Debiopharm (https://www.debiopharm.com/) is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. 50% of Debiopharm employees are former academics and Ingeneers. Debiopharm is composed with 4 different societies: 1) Debiopharm International SA 2) Après-Demain SA 3) Debiopharm Innovation Fund SA in Lausanne 4) Debiopharm Research & Manufacturing SA in Martigny The company propose a visit of the Research & Manufacturing SA society based in Martigny
|
Program | Meeting at the Debiopharm lab, Martigny
- Manufacture of controlled-release drugs such as: Decapeptyl®/Trelstar®/Pamorelin®, a drug for the treatment of advanced prostate cancer and certain hormone-dependent diseases in women - Manufacture of controlled-release drugs such as: Fabiotic®, a drug for the treatment of bacterial infections)
|
Location |
Debiopharm Martigny |
Information | |
Expenses | Travel expenses are covered by CUSO |
Registration | Deadline 15.09.2022 Cancellation : before 15.09.2022 |
Places | 20 |
Deadline for registration | 15.09.2022 |
Contact | In case of question, please write to us at microbiologie(at)cuso(dot)ch |